Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,585.35
(
-0.59%
)
US TECH 100
23,612.20
(
-0.77%
)
Dow Jones
45,886.97
(
-0.73%
)
Brent Oil
107.66
(
1.01%
)
Bitcoin
69,471.84
(
-2.48%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 63
Posts 6884
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: mcbio post# 132345

Monday, 12/05/2011 10:09:07 AM

Monday, December 05, 2011 10:09:07 AM

Post# of 257259
XNPT Parkinson's drug no better than standard of care

http://www.reuters.com/article/2011/12/05/xenoport-idUSL3E7N52PD20111205

... The company said it plans to discuss the trial data with Parkinson's disease experts and will defer further investment in the program pending the outcome of its data analysis...

XP21279... a sustained release version of existing treatment Sinemet (levodopa/carbidopa) [which is now generic]
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now